Lim, VG;
Bell, RM;
Arjun, S;
Kolatsi-Joannou, MK;
Long, DA;
Yellon, D;
(2018)
SGLT2 inhibitor, Canagliflozin, attenuates myocardial infarction in the diabetic and non-diabetic heart.
JACC: Basic to Translational Science
10.1016/j.jacbts.2018.10.002.
(In press).
![]() |
Slideshow
Figures for JACC July 2018.pptx - Accepted Version Download (6MB) |
Preview |
Text
Bell JBTS082418-0175-T - SGLT2 inhibitor cardioprotection.pdf - Accepted Version Download (654kB) | Preview |
Preview |
Text
Bell JACC July 2018 - Supplementary material Methods and results.pdf - Accepted Version Download (1MB) | Preview |
Downloads since deposit
1,098Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
![]() |
View Item |